NCT06066060View on ClinicalTrials.gov

A DDI Study of JMKX000623 and Metformin Hydrochloride

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 17, 2023

Primary Completion Date

November 6, 2023

Study Completion Date

November 6, 2023

Conditions
HealthyDrug-Drug Interaction
Interventions
DRUG

JMKX000623

JMKX000623, administered orally ;

DRUG

Metformin

Metformin,administered orally

Trial Locations (1)

Unknown

Huashan Hospital Fudan University, Shanghai

Sponsors

Lead Sponsor

Jemincare
All Listed Sponsors
lead

Jemincare

INDUSTRY

NCT06066060 - A DDI Study of JMKX000623 and Metformin Hydrochloride | Biotech Hunter | Biotech Hunter